118 related articles for article (PubMed ID: 36508303)
1. Post-induction lymph node delineation in nasopharyngeal cancer: A single-center experience.
Sari SY; Yigit E; Yazici G; Gullu IH; Aksoy S; Ozyigit G; Cengiz M
Head Neck; 2023 Mar; 45(3):612-619. PubMed ID: 36508303
[TBL] [Abstract][Full Text] [Related]
2. [Impact of changing gross tumor volume delineation of intensity-modulated radiotherapy on the dose distribution and clinical treatment outcome after induction chemotherapy for the primary locoregionally advanced nasopharyngeal carcinoma].
Yu Z; Luo W; Zhou QC; Zhang QH; Kang DH; Liu MZ
Ai Zheng; 2009 Nov; 28(11):1132-7. PubMed ID: 19895731
[TBL] [Abstract][Full Text] [Related]
3. Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study.
Zhao C; Miao JJ; Hua YJ; Wang L; Han F; Lu LX; Xiao WW; Wu HJ; Zhu MY; Huang SM; Lin CG; Deng XW; Xie CH
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):836-844. PubMed ID: 30954521
[TBL] [Abstract][Full Text] [Related]
4. Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.
Li Y; Bi J; Pi G; He H; Li Y; Zheng D; Wei Z; Han G
Cancer Med; 2023 Apr; 12(8):9449-9457. PubMed ID: 36872566
[TBL] [Abstract][Full Text] [Related]
5. Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: a study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial.
Liu Y; Han Y; Liu F; Hu D; Chen Z; Wang P; Li J; Qin J; Jin F; Li Y; Wang J; Yi J
BMC Cancer; 2023 Aug; 23(1):724. PubMed ID: 37537541
[TBL] [Abstract][Full Text] [Related]
6. Delineation of Neck Clinical Target Volume Specific to Nasopharyngeal Carcinoma Based on Lymph Node Distribution and the International Consensus Guidelines.
Lin L; Lu Y; Wang XJ; Chen H; Yu S; Tian J; Zhou GQ; Zhang LL; Qi ZY; Hu J; Ma J; Sun Y
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):891-902. PubMed ID: 29485068
[TBL] [Abstract][Full Text] [Related]
7. Tumor Volume Reduction After Gemcitabine Plus Cisplatin Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer: Comparison with Paclitaxel and Cisplatin Regimens.
Zheng L; Liao W; Xu P; Li B; Wen H; Zhang S
Med Sci Monit; 2018 Nov; 24():8001-8008. PubMed ID: 30406770
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
[TBL] [Abstract][Full Text] [Related]
9. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
10. Local and Lymph Node Relapse of Nasopharyngeal Carcinoma: A Single-Center Experience.
Toumi N; Ennouri S; Charfeddine I; Daoud J; Khanfir A
Ear Nose Throat J; 2021 Sep; 100(5_suppl):795S-800S. PubMed ID: 32141322
[TBL] [Abstract][Full Text] [Related]
11. Impact of tumor volume enlargement after induction chemotherapy on subsequent radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity-score matching analysis.
Li S; Shen L
Cancer Med; 2020 Dec; 9(23):8832-8843. PubMed ID: 33022902
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.
Zeng L; Zhang Q; Ao F; Jiang CL; Xiao Y; Xie HH; Tang YQ; Gong XC; Li JG
Auris Nasus Larynx; 2019 Jun; 46(3):457-464. PubMed ID: 30528104
[TBL] [Abstract][Full Text] [Related]
13. Posterior cervical lymph node metastasis as the valuable prognostic factor for stage IVA/IVB nasopharyngeal carcinoma treated with induction chemotherapy followed by concurrent chemo-radiotherapy.
Thephamongkhol K; Setakornnukul J; Rojwatkarnjana S; Chansilpa Y
Int J Biol Markers; 2014 Dec; 29(4):e387-94. PubMed ID: 25198554
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of the ratio of standard uptake value of lymph node to primary tumor before treatment of locally advanced nasopharyngeal carcinoma.
Lou Y; Chen D; Lin Z; Sun J; Song L; Chen W; Zhang M; Chen Y
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):347-356. PubMed ID: 35932312
[TBL] [Abstract][Full Text] [Related]
15. A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma.
Chen J; Qi J; Yu B; Peng XH; Wang F; Tan JJ; Chen QQ; Peng XY; Zeng FF; Liu X
Med Sci Monit; 2018 Apr; 24():2562-2568. PubMed ID: 29697098
[TBL] [Abstract][Full Text] [Related]
16. Level Ib CTV delineation in nasopharyngeal carcinoma based on lymph node distribution and topographic anatomy.
Zhao Y; Liao X; Wang Y; Lan W; Ren J; Yang N; Li C; Lang J; Zhang S
Radiother Oncol; 2022 Jul; 172():10-17. PubMed ID: 35500787
[TBL] [Abstract][Full Text] [Related]
17. Local control and failure patterns after intensity modulated radiotherapy with reduced target volume delineation after induction chemotherapy for patients with T4 nasopharyngeal carcinoma.
Kong FF; Ni MS; Zhai RP; Ying HM; Hu CS
Transl Oncol; 2022 Feb; 16():101324. PubMed ID: 34953342
[TBL] [Abstract][Full Text] [Related]
18. Sequential induction chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three-year report of a phase II, single center, randomized, non-inferiority trial.
Yang Z; Cai Z; Cai Q; Hong Y; Zhang C; Huang K; Lin Z; Li M
Cancer Med; 2021 Jun; 10(12):3886-3895. PubMed ID: 33955190
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
[TBL] [Abstract][Full Text] [Related]
20. Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma.
Wang Q; Xu G; Xia Y; Zuo J; Zeng G; Xue Z; Cao R; Xiong W; Li W
Oral Oncol; 2020 Dec; 111():104925. PubMed ID: 32721816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]